Quais são as probabilidades atuais de Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028??

A Manifold Markets cota No em 68.6% em 30 de outubro de 2026.

Negociar em simulação

Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?

Saúde e medicinaOne-Off1a

Manifold MarketsSem KYCDados de resolução verificadosBem calibrado

Previsão da comunidade atual

Não 68.6%

Previsores

Tipo de pergunta

binary

Metodologia

Play-money forecasting platform

Tipo de fonte

Previsão

Dados do mercado

Atualizado há 21 horas

Desatualizado

21/02/23, 20:24 UTC31/12/27, 22:59 UTC

Tendências

Resultado24hProbabilidade

Regras

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of colorectal adenocarcinoma in the United States before January 1, 2028.

This does not include emergency use authorization or other forms of limited authorization.
Resolves NO otherwise.

Reportar um problema de dados deste mercado

Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?

Will FDA approve any mRNA vaccine against colorectal adenocarcinoma before 2028?

Mercados abertos

Hantavirus pandemic in 2026?

Measles cases in 2026?

Measles cases in U.S. in 2026?

Measles cases in U.S. by October 31?

When will the FDA reclassify BPC-157 to Category 1?

What will Yum! Brands say during their next earnings call?

Perguntas frequentes

Use este mercado em código ou em um agente de IA

Mercados abertos

Hantavirus pandemic in 2026?

Measles cases in 2026?

Measles cases in U.S. in 2026?

Measles cases in U.S. by October 31?

When will the FDA reclassify BPC-157 to Category 1?

What will Yum! Brands say during their next earnings call?